bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 26.8% in September

bioMérieux S.A. (OTCMKTS:BMXMF) saw a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 165,200 shares, a decline of 26.8% from the August 31st total of 225,800 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 1,652.0 days.

Analyst Upgrades and Downgrades

Separately, UBS Group upgraded shares of bioMérieux to a “strong-buy” rating in a report on Thursday, August 22nd.

bioMérieux Stock Performance

BMXMF remained flat at $117.36 during trading hours on Friday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.19 and a current ratio of 2.03. The stock has a 50 day moving average price of $112.26 and a 200-day moving average price of $106.50. bioMérieux has a 52-week low of $90.23 and a 52-week high of $122.52.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.